European Declaration on Epilepsy

25. October 1998


At a meeting in Heidelberg, Germany on 25 October 1998, over 100 leaders of European professional and Iay bodies, WHO representatives and health experts from governments and universities unanimously agreed the following declaration:


We call on the governments of Europe, the European Union, and all health care providers to join us in taking strong and decisive action to meet the objectives of the Global Campaign against Epilepsy launched by the WHO, ILAE, and IBE.

Specifically, we urge action:

- to improve public understanding of epilepsy and thereby reduce its stigma

- to remove discrimination against people with epilepsy in the workplace

- to help people with epilepsy to understand their condition and to empower them to seek appropriate treatment and lead fulfilled lives

- to improve the knowledge of health care professionals and other professionals about epilepsy, before and after graduation

- to ensure the availability of modern equipment, facilities, trained personnel and the full range of antiepileptic drugs, so that an accurate diagnosis can be made leading to the most effective treatment

- to encourage research on epilepsy and its management

- to encourage close liason among governments, health and social authorities and agencies, and the national chapters of the ILAE and IBE

- to support the publication of a "white paper" as a detailed Public Health statement on Epilepsy in Europe

- to provide practical assistance for countries with underdeveloped epilepsy services within and beyond Europe


Background Note

Epilepsy is the commonest serious brain disorder in every country, and probably the most universal of all medical disorders. lt occurs at all ages, especially in childhood and old age, and in all races and social classes. At least 40 million people world-wide have epilepsy. One hundred million people will have epilepsy at some time in their lives.

Epilepsy is widely misunderstood, leading to fear, secrecy, stigmatisation, and the risk of social and legal penalties. In some European countries it is still not recognised as a brain disorder and up to 40% of people with epilepsy may be untreated - the treatment gap. The life span of people with epilepsy is reduced. Indeed, in specific risk groups the mortality may be twice or more that of the general population.

The ILAE has published a document on "Appropriate standards of epilepsy care across Europe". However, professionals treating people with epilepsy often do not have sufficient specialised knowledge about the condition. In some countries, antiepileptic drugs are not always available or are unaffordable. In a number of European countries diagnostic facilities are lacking or inadequate.
Although WHO and World Bank studies have shown that epilepsy is a considerable economic burden, very few European countries have national plans for epilepsy.

Epilepsy has profound physical, psychological, and social consequences:



The objectives of the Global Campaign against Epilepsy of the World Health Organisation, International League against Epilepsy, and International Bureau for Epilepsy are:


     
International Bureau
of Epilepsy

PO Box 21
2100 AA Hemsteede
The Netherlands
Tel: 00 23 523 74 11
or 00 23 529 10 19
Fax: 00 23 547 01 19
World Health
Organisation

1211 Geneva 27
Switzerland
Tel: 00 41 22 791 2111
Fax: 00 41 22 791 0746
Cables: UNISANTE-GENEVA
Telex 415 416
International League
Against Epilepsy

Epilepsie Zentrum Bethel
Mara 1 - Maraweg 21
Bethel - 33617 Bielefeld
Germany
Tel: 00 49 521 144 4897
Fax: 00 49 521 144 4637